Skip to content
10-K

Annual Report

TETRALOGIC PHARMACEUTICALS CORP

0001558370-16-004186

← back to feed
Filed
Mar 16, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 10, 2016 24.77M sh
Shares Diluted FY 2015 · Dec 31, 2015 23.73M sh
Shares Diluted FY 2015 · Dec 31, 2014 22.35M sh
Capex FY 2015 · Dec 31, 2015 $77.33K
Capex FY 2015 · Dec 31, 2014 $514.86K
Cash And Equivalents FY 2015 · Dec 31, 2015 $15.3M
Cash And Equivalents FY 2015 · Dec 31, 2014 $13.07M
Cash And Equivalents FY 2015 · Dec 31, 2013 $55.14M
Stockholders Equity FY 2015 · Dec 31, 2015 −$5.94M
Stockholders Equity FY 2015 · Dec 31, 2014 $33.4M
Stockholders Equity FY 2015 · Dec 31, 2013 $50.55M
Current Liabilities FY 2015 · Dec 31, 2015 $3.66M
Current Liabilities FY 2015 · Dec 31, 2014 $5.12M
Total Liabilities FY 2015 · Dec 31, 2015 $69.96M
Total Liabilities restated FY 2015 · Dec 31, 2014 $83.21M
Current Assets FY 2015 · Dec 31, 2015 $21.97M
Current Assets restated FY 2015 · Dec 31, 2014 $55.48M
Total Assets FY 2015 · Dec 31, 2015 $64.02M
Total Assets restated FY 2015 · Dec 31, 2014 $116.62M
Eps Diluted FY 2015 · Dec 31, 2015 −$2.10
Eps Diluted FY 2015 · Dec 31, 2014 −$1.63
Eps Basic FY 2015 · Dec 31, 2015 −$2.10
Eps Basic FY 2015 · Dec 31, 2014 −$1.61
Sga Expense FY 2015 · Dec 31, 2015 $11.1M
Sga Expense FY 2015 · Dec 31, 2014 $10.93M
Rd Expense FY 2015 · Dec 31, 2015 $27.4M
Rd Expense FY 2015 · Dec 31, 2014 $20.29M
Net Income FY 2015 · Dec 31, 2015 −$49.72M
Net Income FY 2015 · Dec 31, 2014 −$35.96M
Operating Income FY 2015 · Dec 31, 2015 −$44.99M
Operating Income FY 2015 · Dec 31, 2014 −$33.79M
Revenue FY 2015 · Dec 31, 2015 $0